Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 229 entries
Sorted by: Best Match Show Resources per page
How to Best Name a Place? Facilitation and Inhibition of Route Learning Due to Descriptive and Arbitrary Location Labels.

Frontiers in psychology

Meilinger T, Schulte-Pelkum J, Frankenstein J, Hardiess G, Laharnar N, Mallot HA, Bülthoff HH.
PMID: 26869975
Front Psychol. 2016 Feb 01;7:76. doi: 10.3389/fpsyg.2016.00076. eCollection 2016.

Establishing verbal memory traces for non-verbal stimuli was reported to facilitate or inhibit memory for the non-verbal stimuli. We show that these effects are also observed in a domain not indicated before-wayfinding. Fifty-three participants followed a guided route in...

Cite
Meilinger T, Schulte-Pelkum J, Frankenstein J, et al. How to Best Name a Place? Facilitation and Inhibition of Route Learning Due to Descriptive and Arbitrary Location Labels. Front Psychol. 2016;7:76doi: 10.3389/fpsyg.2016.00076.
Meilinger, T., Schulte-Pelkum, J., Frankenstein, J., Hardiess, G., Laharnar, N., Mallot, H. A., & Bülthoff, H. H. (2016). How to Best Name a Place? Facilitation and Inhibition of Route Learning Due to Descriptive and Arbitrary Location Labels. Frontiers in psychology, 776. https://doi.org/10.3389/fpsyg.2016.00076
Meilinger, Tobias, et al. "How to Best Name a Place? Facilitation and Inhibition of Route Learning Due to Descriptive and Arbitrary Location Labels." Frontiers in psychology vol. 7 (2016): 76. doi: https://doi.org/10.3389/fpsyg.2016.00076
Meilinger T, Schulte-Pelkum J, Frankenstein J, Hardiess G, Laharnar N, Mallot HA, Bülthoff HH. How to Best Name a Place? Facilitation and Inhibition of Route Learning Due to Descriptive and Arbitrary Location Labels. Front Psychol. 2016 Feb 01;7:76. doi: 10.3389/fpsyg.2016.00076. eCollection 2016. PMID: 26869975; PMCID: PMC4734103.
Copy Download .nbib Format: NLM
Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.

ACS medicinal chemistry letters

Wilson DL, Meininger I, Strater Z, Steiner S, Tomlin F, Wu J, Jamali H, Krappmann D, Götz MG.
PMID: 26985310
ACS Med Chem Lett. 2016 Jan 15;7(3):250-5. doi: 10.1021/acsmedchemlett.5b00401. eCollection 2016 Mar 10.

This research explores the first design and synthesis of macrocyclic peptide aldehydes as potent inhibitors of the 20S proteasome. Two novel macrocyclic peptide aldehydes based on the ring-size of the macrocyclic natural product TMC-95 were prepared and evaluated as...

Cite
Wilson DL, Meininger I, Strater Z, et al. Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome. ACS Med Chem Lett. 2016;7(3):250-5doi: 10.1021/acsmedchemlett.5b00401.
Wilson, D. L., Meininger, I., Strater, Z., Steiner, S., Tomlin, F., Wu, J., Jamali, H., Krappmann, D., & Götz, M. G. (2016). Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome. ACS medicinal chemistry letters, 7(3), 250-5. https://doi.org/10.1021/acsmedchemlett.5b00401
Wilson, David L, et al. "Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome." ACS medicinal chemistry letters vol. 7,3 (2016): 250-5. doi: https://doi.org/10.1021/acsmedchemlett.5b00401
Wilson DL, Meininger I, Strater Z, Steiner S, Tomlin F, Wu J, Jamali H, Krappmann D, Götz MG. Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome. ACS Med Chem Lett. 2016 Jan 15;7(3):250-5. doi: 10.1021/acsmedchemlett.5b00401. eCollection 2016 Mar 10. PMID: 26985310; PMCID: PMC4789680.
Copy Download .nbib Format: NLM
[A modified step test for measuring the load capacity of the circulation].

Deutsche medizinische Wochenschrift (1946)

HETTINGER T, RODAHL K.
PMID: 14401542
Dtsch Med Wochenschr. 1960 Apr 01;85:553-7. doi: 10.1055/s-0028-1112470.

No abstract available.

Cite
HETTINGER T, RODAHL K. [A modified step test for measuring the load capacity of the circulation]. Dtsch Med Wochenschr. 1960;85:553-7doi: 10.1055/s-0028-1112470.
HETTINGER, T., & RODAHL, K. (1960). [A modified step test for measuring the load capacity of the circulation]. Deutsche medizinische Wochenschrift (1946), 85553-7. https://doi.org/10.1055/s-0028-1112470
HETTINGER, T, and RODAHL, K. "[A modified step test for measuring the load capacity of the circulation]." Deutsche medizinische Wochenschrift (1946) vol. 85 (1960): 553-7. doi: https://doi.org/10.1055/s-0028-1112470
HETTINGER T, RODAHL K. [A modified step test for measuring the load capacity of the circulation]. Dtsch Med Wochenschr. 1960 Apr 01;85:553-7. doi: 10.1055/s-0028-1112470. German. PMID: 14401542.
Copy Download .nbib Format: NLM
Acetogenesis from dichloromethane by a two-component mixed culture comprising a novel bacterium.

Applied and environmental microbiology

Magli A, Rainey FA, Leisinger T.
PMID: 16535097
Appl Environ Microbiol. 1995 Aug;61(8):2943-9. doi: 10.1128/aem.61.8.2943-2949.1995.

A strictly anaerobic two-component culture able to grow exponentially with a doubling time of 20 h on a medium containing dichloromethane as the carbon and energy source was characterized. On a medium without sulfate, we observed (per mol of...

Cite
Magli A, Rainey FA, Leisinger T. Acetogenesis from dichloromethane by a two-component mixed culture comprising a novel bacterium. Appl Environ Microbiol. 1995;61(8):2943-9doi: 10.1128/aem.61.8.2943-2949.1995.
Magli, A., Rainey, F. A., & Leisinger, T. (1995). Acetogenesis from dichloromethane by a two-component mixed culture comprising a novel bacterium. Applied and environmental microbiology, 61(8), 2943-9. https://doi.org/10.1128/aem.61.8.2943-2949.1995
Magli, A, et al. "Acetogenesis from dichloromethane by a two-component mixed culture comprising a novel bacterium." Applied and environmental microbiology vol. 61,8 (1995): 2943-9. doi: https://doi.org/10.1128/aem.61.8.2943-2949.1995
Magli A, Rainey FA, Leisinger T. Acetogenesis from dichloromethane by a two-component mixed culture comprising a novel bacterium. Appl Environ Microbiol. 1995 Aug;61(8):2943-9. doi: 10.1128/aem.61.8.2943-2949.1995. PMID: 16535097; PMCID: PMC1388551.
Copy Download .nbib Format: NLM
Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours.

Journal of Cancer

Mairinger FD, Walter RF, Theegarten D, Hager T, Vollbrecht C, Christoph DC, Worm K, Ting S, Werner R, Stamatis G, Mairinger T, Baba H, Zarogoulidis K, Huang H, Li Q, Tsakiridis K, Zarogoulidis P, Schmid KW, Wohlschlaeger J.
PMID: 25157275
J Cancer. 2014 Aug 01;5(8):646-54. doi: 10.7150/jca.9955. eCollection 2014.

BACKGROUND: Proteasomal subunit PSMB4 was suggested to be a survival gene in an animal model of hepatocellular carcinoma and in glioblastoma cell lines. In pulmonary adenocarcinoma, a high expression of these genes was found to be associated with poor...

Cite
Mairinger FD, Walter RF, Theegarten D, et al. Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours. J Cancer. 2014;5(8):646-54doi: 10.7150/jca.9955.
Mairinger, F. D., Walter, R. F., Theegarten, D., Hager, T., Vollbrecht, C., Christoph, D. C., Worm, K., Ting, S., Werner, R., Stamatis, G., Mairinger, T., Baba, H., Zarogoulidis, K., Huang, H., Li, Q., Tsakiridis, K., Zarogoulidis, P., Schmid, K. W., & Wohlschlaeger, J. (2014). Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours. Journal of Cancer, 5(8), 646-54. https://doi.org/10.7150/jca.9955
Mairinger, Fabian Dominik, et al. "Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours." Journal of Cancer vol. 5,8 (2014): 646-54. doi: https://doi.org/10.7150/jca.9955
Mairinger FD, Walter RF, Theegarten D, Hager T, Vollbrecht C, Christoph DC, Worm K, Ting S, Werner R, Stamatis G, Mairinger T, Baba H, Zarogoulidis K, Huang H, Li Q, Tsakiridis K, Zarogoulidis P, Schmid KW, Wohlschlaeger J. Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours. J Cancer. 2014 Aug 01;5(8):646-54. doi: 10.7150/jca.9955. eCollection 2014. PMID: 25157275; PMCID: PMC4142326.
Copy Download .nbib Format: NLM
Ab initio study of valence and Rydberg states of CH3Br.

The Journal of chemical physics

Escure C, Leininger T, Lepetit B.
PMID: 19566152
J Chem Phys. 2009 Jun 28;130(24):244306. doi: 10.1063/1.3152865.

We performed configuration interaction ab initio calculations on the valence and 5s, 5p(a(1)), and 5p(e) Rydberg bands of the CH(3)Br molecule as a function of the methyl-bromide distance for frozen C(3v) geometries. The valence state potential energy curves are...

Cite
Escure C, Leininger T, Lepetit B. Ab initio study of valence and Rydberg states of CH3Br. J Chem Phys. 2009;130(24):244306doi: 10.1063/1.3152865.
Escure, C., Leininger, T., & Lepetit, B. (2009). Ab initio study of valence and Rydberg states of CH3Br. The Journal of chemical physics, 130(24), 244306. https://doi.org/10.1063/1.3152865
Escure, Christelle, et al. "Ab initio study of valence and Rydberg states of CH3Br." The Journal of chemical physics vol. 130,24 (2009): 244306. doi: https://doi.org/10.1063/1.3152865
Escure C, Leininger T, Lepetit B. Ab initio study of valence and Rydberg states of CH3Br. J Chem Phys. 2009 Jun 28;130(24):244306. doi: 10.1063/1.3152865. PMID: 19566152.
Copy Download .nbib Format: NLM
Psychological influences on distance estimation in a virtual reality environment.

Frontiers in human neuroscience

Takahashi K, Meilinger T, Watanabe K, Bülthoff HH.
PMID: 24065905
Front Hum Neurosci. 2013 Sep 18;7:580. doi: 10.3389/fnhum.2013.00580. eCollection 2013.

Studies of embodied perception have revealed that social, psychological, and physiological factors influence space perception. While many of these influences were observed with real or highly realistic stimuli, the present work showed that even the orientation of abstract geometric...

Cite
Takahashi K, Meilinger T, Watanabe K, et al. Psychological influences on distance estimation in a virtual reality environment. Front Hum Neurosci. 2013;7:580doi: 10.3389/fnhum.2013.00580.
Takahashi, K., Meilinger, T., Watanabe, K., & Bülthoff, H. H. (2013). Psychological influences on distance estimation in a virtual reality environment. Frontiers in human neuroscience, 7580. https://doi.org/10.3389/fnhum.2013.00580
Takahashi, Kohske, et al. "Psychological influences on distance estimation in a virtual reality environment." Frontiers in human neuroscience vol. 7 (2013): 580. doi: https://doi.org/10.3389/fnhum.2013.00580
Takahashi K, Meilinger T, Watanabe K, Bülthoff HH. Psychological influences on distance estimation in a virtual reality environment. Front Hum Neurosci. 2013 Sep 18;7:580. doi: 10.3389/fnhum.2013.00580. eCollection 2013. PMID: 24065905; PMCID: PMC3776303.
Copy Download .nbib Format: NLM
Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis.

Frontiers in immunology

Harutyunyan G, Hauer L, Dünser MW, Moser T, Pikija S, Leitinger M, Novak HF, Aichhorn W, Trinka E, Sellner J.
PMID: 28804482
Front Immunol. 2017 Jul 28;8:835. doi: 10.3389/fimmu.2017.00835. eCollection 2017.

BACKGROUND: Prevention and early recognition of critical illness in patients with autoimmune encephalitis (AE) is essential to achieve better outcome.AIM OF THE STUDY: To evaluate risk factors for intensive care unit (ICU) admission and its prognostic impact in patients...

Cite
Harutyunyan G, Hauer L, Dünser MW, et al. Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis. Front Immunol. 2017;8:835doi: 10.3389/fimmu.2017.00835.
Harutyunyan, G., Hauer, L., Dünser, M. W., Moser, T., Pikija, S., Leitinger, M., Novak, H. F., Aichhorn, W., Trinka, E., & Sellner, J. (2017). Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis. Frontiers in immunology, 8835. https://doi.org/10.3389/fimmu.2017.00835
Harutyunyan, Gayane, et al. "Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis." Frontiers in immunology vol. 8 (2017): 835. doi: https://doi.org/10.3389/fimmu.2017.00835
Harutyunyan G, Hauer L, Dünser MW, Moser T, Pikija S, Leitinger M, Novak HF, Aichhorn W, Trinka E, Sellner J. Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis. Front Immunol. 2017 Jul 28;8:835. doi: 10.3389/fimmu.2017.00835. eCollection 2017. PMID: 28804482; PMCID: PMC5532517.
Copy Download .nbib Format: NLM
Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus.

Journal of clinical & translational endocrinology

Qiu R, Capuano G, Meininger G.
PMID: 29159083
J Clin Transl Endocrinol. 2014 May 05;1(2):54-60. doi: 10.1016/j.jcte.2014.04.001. eCollection 2014 Jun.

AIM: To evaluate the efficacy/safety of canagliflozin twice daily (BID) compared with placebo in patients with type 2 diabetes mellitus (T2DM) on metformin.METHODS: In this 18-week, randomized, double-blind, placebo-controlled study, patients (RESULTS: From a mean baseline HbACONCLUSIONS: Canagliflozin 50...

Cite
Qiu R, Capuano G, Meininger G. Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus. J Clin Transl Endocrinol. 2014;1(2):54-60doi: 10.1016/j.jcte.2014.04.001.
Qiu, R., Capuano, G., & Meininger, G. (2014). Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus. Journal of clinical & translational endocrinology, 1(2), 54-60. https://doi.org/10.1016/j.jcte.2014.04.001
Qiu, Rong, et al. "Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus." Journal of clinical & translational endocrinology vol. 1,2 (2014): 54-60. doi: https://doi.org/10.1016/j.jcte.2014.04.001
Qiu R, Capuano G, Meininger G. Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus. J Clin Transl Endocrinol. 2014 May 05;1(2):54-60. doi: 10.1016/j.jcte.2014.04.001. eCollection 2014 Jun. PMID: 29159083; PMCID: PMC5685027.
Copy Download .nbib Format: NLM
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India.

Indian journal of endocrinology and metabolism

Prasanna Kumar KM, Mohan V, Sethi B, Gandhi P, Bantwal G, Xie J, Meininger G, Qiu R.
PMID: 27186557
Indian J Endocrinol Metab. 2016 May-Jun;20(3):372-80. doi: 10.4103/2230-8210.179996.

BACKGROUND: This post hoc analysis evaluated the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) from India.METHODS: Changes from baseline in HbA1c, fasting plasma glucose (FPG), body weight,...

Cite
Prasanna Kumar KM, Mohan V, Sethi B, et al. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India. Indian J Endocrinol Metab. 2016;20(3):372-80doi: 10.4103/2230-8210.179996.
Prasanna Kumar, K. M., Mohan, V., Sethi, B., Gandhi, P., Bantwal, G., Xie, J., Meininger, G., & Qiu, R. (2016). Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India. Indian journal of endocrinology and metabolism, 20(3), 372-80. https://doi.org/10.4103/2230-8210.179996
Prasanna Kumar, K M, et al. "Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India." Indian journal of endocrinology and metabolism vol. 20,3 (2016): 372-80. doi: https://doi.org/10.4103/2230-8210.179996
Prasanna Kumar KM, Mohan V, Sethi B, Gandhi P, Bantwal G, Xie J, Meininger G, Qiu R. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from India. Indian J Endocrinol Metab. 2016 May-Jun;20(3):372-80. doi: 10.4103/2230-8210.179996. PMID: 27186557; PMCID: PMC4855968.
Copy Download .nbib Format: NLM
Factors such as regulatory proteins, mRNA and miRNA are transported by stem cell specific microparticles that are released into the cerebprospinal fluid following traumatic brain injury (TBI).

Journal of stem cells & regenerative medicine

Schäfer U, Grünbacher G, Trattnig C, Fasching U, Novak A, Waldispühl-Geigl J, Leitinger G, Gülly C, Patz S.
PMID: 24693061
J Stem Cells Regen Med. 2010 Oct 23;6(2):39-40. eCollection 2010.

No abstract available.

Cite
Schäfer U, Grünbacher G, Trattnig C, et al. Factors such as regulatory proteins, mRNA and miRNA are transported by stem cell specific microparticles that are released into the cerebprospinal fluid following traumatic brain injury (TBI). J Stem Cells Regen Med. 2010;6(2):39-40
Schäfer, U., Grünbacher, G., Trattnig, C., Fasching, U., Novak, A., Waldispühl-Geigl, J., Leitinger, G., Gülly, C., & Patz, S. (2010). Factors such as regulatory proteins, mRNA and miRNA are transported by stem cell specific microparticles that are released into the cerebprospinal fluid following traumatic brain injury (TBI). Journal of stem cells & regenerative medicine, 6(2), 39-40.
Schäfer, U, et al. "Factors such as regulatory proteins, mRNA and miRNA are transported by stem cell specific microparticles that are released into the cerebprospinal fluid following traumatic brain injury (TBI)." Journal of stem cells & regenerative medicine vol. 6,2 (2010): 39-40.
Schäfer U, Grünbacher G, Trattnig C, Fasching U, Novak A, Waldispühl-Geigl J, Leitinger G, Gülly C, Patz S. Factors such as regulatory proteins, mRNA and miRNA are transported by stem cell specific microparticles that are released into the cerebprospinal fluid following traumatic brain injury (TBI). J Stem Cells Regen Med. 2010 Oct 23;6(2):39-40. eCollection 2010. PMID: 24693061.
Copy Download .nbib Format: NLM
Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma.

Cancer management and research

Walter RFH, Sydow SR, Berg E, Kollmeier J, Christoph DC, Christoph S, Eberhardt WEE, Mairinger T, Wohlschlaeger J, Schmid KW, Mairinger FD.
PMID: 31576173
Cancer Manag Res. 2019 Sep 24;11:8711-8720. doi: 10.2147/CMAR.S194337. eCollection 2019.

BACKGROUND: Bortezomib is an approved proteasome inhibitor for the treatment of certain lymphoma subtypes. Two clinical trials investigated bortezomib in patients with malignant pleural mesothelioma (MPM) and failed to improve outcome. We present a potential explanation for this event.METHODS:...

Cite
Walter RFH, Sydow SR, Berg E, et al. Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma. Cancer Manag Res. 2019;11:8711-8720doi: 10.2147/CMAR.S194337.
Walter, R. F. H., Sydow, S. R., Berg, E., Kollmeier, J., Christoph, D. C., Christoph, S., Eberhardt, W. E. E., Mairinger, T., Wohlschlaeger, J., Schmid, K. W., & Mairinger, F. D. (2019). Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma. Cancer management and research, 118711-8720. https://doi.org/10.2147/CMAR.S194337
Walter, Robert Fred Henry, et al. "Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma." Cancer management and research vol. 11 (2019): 8711-8720. doi: https://doi.org/10.2147/CMAR.S194337
Walter RFH, Sydow SR, Berg E, Kollmeier J, Christoph DC, Christoph S, Eberhardt WEE, Mairinger T, Wohlschlaeger J, Schmid KW, Mairinger FD. Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma. Cancer Manag Res. 2019 Sep 24;11:8711-8720. doi: 10.2147/CMAR.S194337. eCollection 2019. PMID: 31576173; PMCID: PMC6765394.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 229 entries